SCOPUS 정보 검색 플랫폼

Journal of Pain and Symptom Management

Volumn 19, Issue 6, 2000, Pages 405-407

High-dose ketamine in the management of cancer-related neuropathic pain [1]

(4) Tarumi, Yoko a Watanabe, Sharon a Bruera, Eduardo b Ishitani, Kunihiko c

a GREY NUNS COMMUNITY HOSPITAL (Canada)

b UNIVERSITY OF TEXAS (United States)

c Higashi Sapporo Hospital (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; KETAMINE; LIDOCAINE; METHYLPREDNISOLONE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENOL; STEROID;

ADULT; CANCER PAIN; CASE REPORT; FEMALE; HUMAN; LETTER; LUNG METASTASIS; NAUSEA; NEUROPATHY; PARESTHESIA; RECTUM CARCINOMA; RECURRENT CANCER; UTERUS CANCER; VAGINA CANCER;

ANALGESICS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; KETAMINE; MIDDLE AGED; NEOPLASMS; NEURALGIA; PERINEUM;

EID: 0033922025 PISSN: 08853924 EISSN: None Source Type: Journal
DOI: 10.1016/S0885-3924(00)00157-3 Document Type: Letter

Times cited : (13)

References (7)

1
- 0025974775
- The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states
- C.J. Woolf S.W.N. Tompson The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states Pain 44 1991 293 299
- (1991) Pain , vol.44 , pp. 293-299
- Woolf, C.J.¹ Tompson, S.W.N.²

2
- 0025303844
- Continuous subcutaneous injection of ketamine for cancer pain
- F. Oshima K. Tei H. Kayazawa N. Urabe Continuous subcutaneous injection of ketamine for cancer pain Can J Anaesth 37 1990 383 392
- (1990) Can J Anaesth , vol.37 , pp. 383-392
- Oshima, F.¹ Tei, K.² Kayazawa, H.³ Urabe, N.⁴

3
- 0027930209
- Intravenous microdrip infusion of ketamine in subaneathetic doses for intractable terminal cancer pain
- S. Ogawa T. Kanamaru K. Noda Intravenous microdrip infusion of ketamine in subaneathetic doses for intractable terminal cancer pain Pain Clin 7 1994 125 129
- (1994) Pain Clin , vol.7 , pp. 125-129
- Ogawa, S.¹ Kanamaru, T.² Noda, K.³

4
- 0028801234
- Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain
- S. Mercadante F. Lodi M. Sapio M. Calligara R. Serretta Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain J Plain Symptom Manage 10 1995 564 568
- (1995) J Plain Symptom Manage , vol.10 , pp. 564-568
- Mercadante, S.¹ Lodi, F.² Sapio, M.³ Calligara, M.⁴ Serretta, R.⁵

5
- 0030056671
- Ketamine in cancer pain: an update
- S. Mercadante Ketamine in cancer pain an update Palliat Med 10 1996 225 230
- (1996) Palliat Med , vol.10 , pp. 225-230
- Mercadante, S.¹

6
- 0021921829
- Ketamine: behavioral effects of subanesthetic doses
- M.M. Ghoneim J.V. Hinrichs S.P. Mewaldt Ketamine behavioral effects of subanesthetic doses J Clin Psychopharmacol 5 1985 70 77
- (1985) J Clin Psychopharmacol , vol.5 , pp. 70-77
- Ghoneim, M.M.¹ Hinrichs, J.V.² Mewaldt, S.P.³

7
- 0029049804
- Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia
- K. Eide A. Stubhaug I. Oye Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia Pain 61 1995 221 228
- (1995) Pain , vol.61 , pp. 221-228
- Eide, K.¹ Stubhaug, A.² Oye, I.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.